• Skip to homepage
  • Skip to main content
  • Skip to main navigation
  • Skip to meta navigation
Zühlke - zur Startseite
  • Business
  • Careers
  • Events
  • About us

Language navigation. The current language is english

  • Expertise
    • AI implementation
    • Cloud
    • Cybersecurity
    • Data solutions
    • DevOps
    • Digital strategy
    • Experience design
    • Hardware engineering
    • Managed services
    • Software engineering
    • Sustainability transformation
    Explore our expertise

    Highlight Case Study

    Airport concept

    Zurich Airport transforms operations for a data-driven future

    Learn more
  • Industries
    • Banking
    • Insurance
    • Healthcare providers
    • MedTech
    • Pharma
    • Industrial sector
    • Commerce & retail
    • Energy & utilities
    • Government & public sector
    • Transport
    Explore our industries

    Subscribe to recieve the latest news, event invitations & more!

    Sign up here
  • Case studies

    Spotlight case studies

    • Global Research Platforms and Zühlke are fighting Alzheimer's disease
    • Brückner Maschinenbau leverages GenAI to optimise efficiency by improving master data management
    • UNIQA: AI chatbot increases efficiency – 95% accuracy with half the effort
    Explore more case studies

    Highlight Case Study

    Airport concept

    Zurich Airport transforms operations for a data-driven future

    Learn more
  • Insights

    Spotlight insights

    • How to apply low-code technologies in the insurance industry
    • Retail CTO playbook for managing the tech transformation
    • DeepSeek and the rise of open-source AI: A game-changer for businesses?
    Explore more insights

    Highlight Insight

    AI adoption: Rethinking time and purpose in the workplace

    Learn more
  • Academy
  • Contact
    • Austria
    • Bulgaria
    • Germany
    • Hong Kong
    • Portugal
    • Serbia
    • Singapore
    • Switzerland
    • United Kingdom
    • Vietnam

    Subscribe to recieve the latest news, event invitations & more!

    Sign up here
Zühlke - zur Startseite
  • Business
  • Careers
  • Events
  • About us
  • Expertise
    • AI implementation
    • Cloud
    • Cybersecurity
    • Data solutions
    • DevOps
    • Digital strategy
    • Experience design
    • Hardware engineering
    • Managed services
    • Software engineering
    • Sustainability transformation
    Explore our expertise

    Highlight Case Study

    Airport concept

    Zurich Airport transforms operations for a data-driven future

    Learn more
  • Industries
    • Banking
    • Insurance
    • Healthcare providers
    • MedTech
    • Pharma
    • Industrial sector
    • Commerce & retail
    • Energy & utilities
    • Government & public sector
    • Transport
    Explore our industries

    Subscribe to recieve the latest news, event invitations & more!

    Sign up here
  • Case studies

    Spotlight case studies

    • Global Research Platforms and Zühlke are fighting Alzheimer's disease
    • Brückner Maschinenbau leverages GenAI to optimise efficiency by improving master data management
    • UNIQA: AI chatbot increases efficiency – 95% accuracy with half the effort
    Explore more case studies

    Highlight Case Study

    Airport concept

    Zurich Airport transforms operations for a data-driven future

    Learn more
  • Insights

    Spotlight insights

    • How to apply low-code technologies in the insurance industry
    • Retail CTO playbook for managing the tech transformation
    • DeepSeek and the rise of open-source AI: A game-changer for businesses?
    Explore more insights

    Highlight Insight

    AI adoption: Rethinking time and purpose in the workplace

    Learn more
  • Academy
  • Contact
    • Austria
    • Bulgaria
    • Germany
    • Hong Kong
    • Portugal
    • Serbia
    • Singapore
    • Switzerland
    • United Kingdom
    • Vietnam

    Subscribe to recieve the latest news, event invitations & more!

    Sign up here

Language navigation. The current language is english

Homepage zuehlke.com

MedTech

EsoCap: Improving the lives of 370 million people with oesophageal diseases

The oesophagus is a particularly challenging environment for drug delivery. Zühlke supported EsoCap in jointly developing an automated prototype production line for EsoCap's novel drug delivery system. 

Peter Stangier inspecting the automated protype production line

The benefits at a glance 

  • The solution is now ready to be scaled up to automated production, opening up new market opportunities for EsoCap. 

  • Detailed analysis of potential process risks and most critical issues. 

  • Tested, proven, working prototype of the production line as an important milestone basis for further development and scaling. 

  • The working prototype of the production line and detailed specifications provide an excellent basis for negotiations with potential manufacturers.  

Oesophageal diseases such as eosinophilic oesophagitis (EoEEoO), gastroesophageal reflux disease (GERD), Barrett's syndrome and oesophageal cancer affect approximately 370 million people worldwide. Today, topical treatment fails due to the short residence time of ingested drugs in the oesophagus.    

EsoCap's vision is to improve the lives of these patients through targeted, long-lasting, topical therapies for the upper gastrointestinal tract. Zühlke helped EsoCap build a scalable prototype production line in preparation for commercial production. 

The solution of EsoCap will help millions of people with esophagus diseases.

Initial situation & challenge

Ingested medications remain in the oesophagus, in the area between the mouth and stomach, for only a few seconds. Physicians, healthcare providers and patients are looking for effective and safe treatments, and there is still a need for oesophageal-specific drug deposition. 

EsoCap has developed a revolutionary smart drug delivery technology to address this challenge. EsoCap's innovative delivery technology consists of a drug-loaded thin film rolled up in a capsule that unrolls and adheres to the oesophageal mucosa when swallowed. This ensures local drug delivery and prolonged mucosal contact as the film slowly dissolves and delivers the drug locally. 

An initial study in healthy volunteers successfully demonstrated the functionality that this promising, innovative solution is both safe and effective. However, EsoCap faces the challenge of scaling production from laboratory to automated production scale. 

EsoCap therefore turned to Zühlke for assistance in scaling up production and evaluating commercial feasibility. 

“We are pleased to be working with Zühlke on process development for automated production of EsoCap technology.” “We are pleased to be working with Zühlke on process development for automated production of EsoCap technology.”

Dr. Peter Stangier
Dr. Peter Stangier

Director Strategic Planning, EsoCap

From initial manual to automated production

The collaboration between EsoCap and Zühlke targets the entire process of transforming initial manual production into an automated production line that serves as a blueprint for high volumes. State-of-the-art technologies such as virtual reality (VR) or 3D printing will be used to achieve the goal as efficiently as possible. Along the way, the team of highly skilled engineers will constantly reduce identified risks and define requirements for the automated assembly of millions of EsoCaps per year.  

"A major challenge in commercializing our multicomponent formulation is the ability to produce cost-effectively on an industrial scale while maintaining strict sterility and quality standards. With our innovative application design and Zühlke's expertise in process automation, we are well positioned to meet this challenge", said Dr. Peter Stangier, Director Strategic Planning at EsoCap.

The result of this collaboration is a prototype production line that will demonstrate the feasibility of large-scale production.  

EsoCap and Zühlke have begun evaluating potential contract manufacturers who will be able to transfer this prototype to a GMP production environment. 

prototype productionline for capsules from EsoCap

Benefits

With the prototype of an automated production line designed and built by Zühlke, EsoCap can demonstrate that its solution works up to commercial scale, and define the conditions necessary to do so. The prototype allows EsoCap to test and link the different production steps and can be used as a reference model for negotiations with manufacturers.  

Thanks to Zühlke, EsoCap is a big step closer to its goal of supporting the 370 million patients with oesophageal diseases worldwide with its innovative solution.

Explore more case studies

Software engineering

Telemonitoring for high-risk covid patients

Learn more
woman checking telemonitoring device with phone
Software engineering

Designing a next-generation virtual clinical trial platform

Learn more
Obviohealth clincial trial
AI

AO Foundation: AI enables patient privacy breakthrough in clinical applications

Learn more
Federated Learning Pharma
Discover all case studies

Get to know us

  • About us
  • Impact & commitments
  • Facts & figures
  • Careers
  • Event Hub
  • Insights Hub
  • News sign-up

Working with us

  • Our expertise
  • Our industries
  • Case studies
  • Partner ecosystem
  • Training Academy
  • Contact us

Legal

  • Privacy policy
  • Cookie policy
  • Legal notice
  • Modern slavery statement
  • Imprint

Request for proposal

We appreciate your interest in working with us. Please send us your request for proposal and we will contact you within 72 hours.

Request for proposal
© 2025 Zühlke Engineering AG

Follow us

  • External Link to Zühlke LinkedIn Page
  • External Link to Zühlke Facebook Page
  • External Link to Zühlke Instagram Page
  • External Link to Zühlke YouTube Page

Language navigation. The current language is english